课题基金 / 基金详情

项目摘要

项目成果

SOPHIE MOLHOLM的其他基金

相似基金

相关文献

中文摘要
翻译
人类临床表型核心(HCP)的目标是促进人类表型的卓越表现,其中心使命是促进爱因斯坦校园内多元化的跨学科研究团队对智力和发育障碍(IDD)的研究。核心维护一个集中的、易于搜索的、去识别的参与者数据库,供Einstein研究者访问,其中包括有关从神经基因组学和翻译神经成像核心收集数据的信息,并为HCP登记的参与者提供连续性,因为他们遍历不同的核心并参与研究项目。HCP对于RFK-IDDRC的使命至关重要,RFK-IDDRC的使命是推进发育障碍儿童的诊断、预防和治疗,HCP被定位为各种RFK-IDDRC研究人员的中心枢纽,对他们来说,全面的表型分析是理解其工作意义的关键。它增加了对感兴趣人群的访问,提高了在特征良好的临床人群中研究工作的成本效益,并促进了具有不同和互补技能和背景的研究人员之间的合作。
英文摘要
The objective of the Human Clinical Phenotyping Core (HCP) is to promote excellence in human phenotyping, with a central mission to facilitate research on intellectual and developmental disabilities (IDD) by a diverse interdisciplinary team of investigators across the Einstein campus. The Core maintains a centralized easily searchable de-identified database of participants for access by Einstein investigators that includes information about data collection from the Neurogenomics and Translational Neuroimaging Cores, and provides continuity to HCP-enrolled participants as they traverse the different Cores and engage in research projects. The HCP is essential to the mission of the RFK-IDDRC to advance diagnosis, prevention, and treatment of children with developmental disabilities, and is positioned to serve as the central hub for a variety of RFK-IDDRC investigators for whom comprehensive phenotyping is key to understanding the implications of their work. It increases access to the populations of interest, increases the cost-effectiveness of research endeavors in well-characterized clinical populations, and facilitates collaboration among researchers with varied and complementary skill-sets and backgrounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUPPORT FOR THE ROSE F KENNEDY IDDRC P50
HUMAN CLINICAL PHENOTYPING CORE
SUPPORT FOR THE ROSE F KENNEDY IDDRC P50
HUMAN CLINICAL PHENOTYPING CORE
海外基金